Researchers are working to find out if the same technology behind a successful Lyme disease vaccine for dogs can be formulated to offer protection for people.
The project, ReCoast, is a New Orleans-based glass recycling center founded by two Tulane alumni to recycle glass and help the coast.
Tulane recently signed a memorandum of understanding with Kharkiv Polytechnic Institute in Kharkiv to collaborate with faculty from Tulane.
In a Q&A, Tulane Today spoke with Jasmijn Bol about her research on the traits that make employees promotable.
A study co-authored by Tulane researchers shows a new COVID-19 vaccine helps the immune system recognize and defend against SARS-CoV-2.
A new blood test combines nanotechnology with artificial intelligence to diagnose tuberculosis (TB) in children.
Insight Into Diversity magazine has awarded Tulane the 2022 Higher Education Excellence in Diversity (HEED) Award, in the undergraduate category.
The 2021-2022 academic year saw the return of many beloved Tulane traditions, in spite of the lingering pandemic.
The AlphaVac is relatively new to the field of medicine, and Rozenbaum is the first cardiologist in the state to perform the procedure.
Tulane engineers and doctors will develop new technology designed to detect severe COVID-19 complications.
The Tulane School of Public Health and Tropical Medicine and the National Taiwan University (NTU) have established a semester-abroad exchange program for students.
Matthew Burow, associate professor of medicine at the School of Medicine, is leading research that will examine “activated foods.”
